Global Plasma Reagin Rapid (RPR) Test Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Plasma Reagin Rapid (RPR) Test Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
The Rapid Plasma Reagin (RPR) test is a blood test used to screen for syphilis, a sexually transmitted infection (STI) caused by the bacterium Treponema pallidum. The RPR test is a non-treponemal test, meaning it does not directly detect the presence of the syphilis bacterium but instead detects antibodies produced by the body in response to the infection.
Plasma Reagin Rapid (RPR) Test report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Plasma Reagin Rapid (RPR) Test market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Hospitals and Specialty Clinics are the major drivers for the industry.
The global market for the Plasma Reagin Rapid (RPR) test was experiencing steady growth due to the increasing prevalence of sexually transmitted infections (STIs) and the rising awareness about the importance of early detection and treatment. The RPR test is a widely used screening tool for syphilis, one of the most common STIs globally. North America held a significant share in the global RPR test market, driven by a high prevalence of STIs and well-established healthcare infrastructure. The region's focus on preventive healthcare and routine STI testing contributed to market growth. Europe was another prominent market for RPR tests, with increasing awareness about STI testing and government initiatives to control syphilis transmission. The Asia-Pacific region witnessed rapid market growth due to the large population, rising awareness about STIs, and efforts to improve healthcare access in developing countries.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Plasma Reagin Rapid (RPR) Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Cardinal Health
Abbott
BD
Roche Holding
Thermo Fisher Scientific
Siemens
SEKISUI Diagnostics
Immunostics
Novacyt
Arlington Scientific
Lorne Laboratories
Meridian Bioscience
Bio-Rad Laboratories
Mediclone Biotech
Newmarket Biomedical
Segment by Type
Monoclonal Antibodies Test
Immunofluorescence Test
Fluorescent Treponemal Antibody Absorption Test
T. Pallidum Hemagglutination Assay
Hospitals
Specialty Clinics
Diagnostics Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Plasma Reagin Rapid (RPR) Test market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Plasma Reagin Rapid (RPR) Test introduction, etc. Plasma Reagin Rapid (RPR) Test Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Plasma Reagin Rapid (RPR) Test market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Plasma Reagin Rapid (RPR) Test report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Plasma Reagin Rapid (RPR) Test market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Hospitals and Specialty Clinics are the major drivers for the industry.
The global market for the Plasma Reagin Rapid (RPR) test was experiencing steady growth due to the increasing prevalence of sexually transmitted infections (STIs) and the rising awareness about the importance of early detection and treatment. The RPR test is a widely used screening tool for syphilis, one of the most common STIs globally. North America held a significant share in the global RPR test market, driven by a high prevalence of STIs and well-established healthcare infrastructure. The region's focus on preventive healthcare and routine STI testing contributed to market growth. Europe was another prominent market for RPR tests, with increasing awareness about STI testing and government initiatives to control syphilis transmission. The Asia-Pacific region witnessed rapid market growth due to the large population, rising awareness about STIs, and efforts to improve healthcare access in developing countries.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Plasma Reagin Rapid (RPR) Test market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Cardinal Health
Abbott
BD
Roche Holding
Thermo Fisher Scientific
Siemens
SEKISUI Diagnostics
Immunostics
Novacyt
Arlington Scientific
Lorne Laboratories
Meridian Bioscience
Bio-Rad Laboratories
Mediclone Biotech
Newmarket Biomedical
Segment by Type
Monoclonal Antibodies Test
Immunofluorescence Test
Fluorescent Treponemal Antibody Absorption Test
T. Pallidum Hemagglutination Assay
Segment by Application
Hospitals
Specialty Clinics
Diagnostics Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Plasma Reagin Rapid (RPR) Test market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Plasma Reagin Rapid (RPR) Test introduction, etc. Plasma Reagin Rapid (RPR) Test Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Plasma Reagin Rapid (RPR) Test market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices